▲ Peaking
Health
🔮 holds
STAT
Coverage by STAT as tracked by Newsylist.
151trends covered
36broke first
164articles tracked
↑ Rising
Business
🔮 holds
Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D
↑ Rising
Business
🔮 holds
Blue Cross and other insurers eliminate Medicare plans for 320K Minnesotans
↓ Cooling
World
🔮 fades
Trump Administration Finalizes Plan to Lower Drug Prices in Medicare
▲ Peaking
Business
🔮 holds ✗
Beam sues YolTech and Serapha Bio for allegedly stealing its gene editing tech
↑ Rising
Health
🔮 holds ✗
CDC updates measles toll, now counts 2 deaths
◼ Archived
Business
🔮 fades ✓
UniQure’s gene therapy continues to slow Huntington’s progression after four years
▲ Peaking
Health
🔮 holds ✗
Scientists are finally starting to figure out Alzheimer’s
◼ Archived
Business
🔮 holds ✗
Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags
◼ Archived
Health
🔮 fades ✓
America had wiped out measles. Now babies are infected at birth.
◼ Archived
Health
🔮 holds ✗
Is long-term use of GLP-1s safe?
◼ Archived
Health
🔮 holds ✗
For Naomi Gaines-Young, Lindsay Clancy case is the latest that 'could have been prevented'
◼ Archived
Health
🔮 fades ✓
‘We’re literally seeing new forms of measles’: Infectious disease doc warns about scary Pennsylvania development
◼ Archived
Business
🔮 holds ✗
Will FDA advisers recommend a multi-cancer blood test for approval? They'll vote
◼ Archived
Health
🔮 holds ✗
Trump calls for some childhood vaccines be split into smaller doses
◼ Archived
Business
🔮 holds ✗
Grail Catapults 30%-Plus As FDA Mulls Cancer-Detecting Blood Test
◼ Archived
Business
🔮 holds ✗
With pioneering ADHD data, Alkermes eyes orexin agonist as potential ‘company changer’
◼ Archived
Business
🔮 fades ✓
Wegovy maker Novo shares slump as management grilled on pricing, M&A
◼ Archived
Health
🔮 fades ✓
Millions of parents are taking GLP-1s. How should they talk to their kids about it?
◼ Archived
Business
🔮 holds ✗
EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say
◼ Archived
Business
🔮 holds ✗
FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease
◼ Archived
Health
🔮 holds ✗
This Rare Gene Drastically Raises Lung Cancer Risk in People Who Never Smoked
◼ Archived
Business
🔮 holds ✗
Montana’s giving the biotech industry sweeping authority to sell unapproved drugs
◼ Archived
Business
🔮 holds ✗
Medicare to expand its pilot that pays for technology to manage chronic diseases
◼ Archived
Business
🔮 holds ✗
Vera kidney drug Trutakna shows strong final results in Phase 3 trial
◼ Archived
Health
🔮 holds ✗
18-year-old dies in Pennsylvania's 4th measles-associated death
◼ Archived
Business
🔮 holds ✗
Psychedelics Stock, Up 190% This Year, Flies High Again
◼ Archived
Business
🔮 fades ✓
Trump Administration Moves to Integrate A.I. Into Medical Care Despite Concerns
◼ Archived
Business
🔮 holds ✗
No more Nordisk as Novo goes it alone amid rebranding push
◼ Archived
Business
🔮 fades ✓
AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial
◼ Archived
Health
🔮 holds ✗
Pennsylvania woman dies of measles-related complications, local coroner says
◼ Archived
Health
🔮 holds ✗
Scientists boycott American Diabetes Association as fallout of June conference fracas escalates
◼ Archived
Business
🔮 holds ✗
A Promising Heart Drug Failed. What Went So Wrong?
◼ Archived
Health
🔮 holds ✗
Extensive and differential platinum chemotherapy mutagenesis in livers of children
◼ Archived
Business
🔮 holds ✗
FDA names acting heads of drug and vaccine centers to permanent roles
◼ Archived
Health
🔮 fades ✓
Scientists Who Study Sleep and Narcolepsy Win Prestigious Lasker Award
◼ Archived
Health
🔮 holds ✗
From algorithms to patient outcomes — lessons from one of the first randomized trials of AI in medicine
◼ Archived
Business
🔮 holds ✗
Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win
◼ Archived
Business
🔮 holds ✗
Inhibrx claims first win for long-sought immunotherapy target
◼ Archived
Business
🔮 fades ✓
Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test
◼ Archived
Business
🔮 holds ✗
Updated: Novo Nordisk cans 2 more trials of IL-6 heart drug for futility
◼ Archived
Health
🔮 holds ✗
New Migraine Prevention Guidelines Released
◼ Archived
Health
🔮 holds ✗
Landmark pancreatic cancer drug shows potential against lung cancer too
◼ Archived
Business
🔮 fades ✓
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
◼ Archived
Health
🔮 holds ✗
Pig kidney works in human body for 271 days
◼ Archived
Business
🔮 holds ✗
Is Ultragenyx Stock a Buy After GTX-102 Flop? Analysts Point to Commercial Pipeline
◼ Archived
Business
🔮 holds ✗
ARPA-H awards $125M for manufacturing custom RNA therapies on demand
◼ Archived
Business
🔮 holds ✗
Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials
◼ Archived
Business
🔮 holds ✗
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
◼ Archived
Business
🔮 fades ✓
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
◼ Archived
Health
🔮 holds ✗
Monoclonal antibody targeting interleukin-6 achieves sustained reductions in inflammation biomarkers through six months
◼ Archived
Business
🔮 holds ✗
Alnylam’s heart drug troubles take center stage at a cardiology conference
◼ Archived
Business
🔮 fades ✓
China is a Threat to Biotech’s Massive Bull Run
◼ Archived
Business
🔮 holds ✗
The mystery of Moderna’s magic algorithm
◼ Archived
Business
🔮 holds ✗
The Race to Develop More Medicines Like the New Pancreatic Cancer Drug
◼ Archived
Health
🔮 holds ✗
Calcium heart scans sharpen risk estimates mainly for borderline-risk adults
◼ Archived
Health
🔮 holds ✗
New treatments for common cardiovascular risk factor near the market, with billions at stake
◼ Archived
Business
🔮 fades ✓
F.D.A. Approves Drug Poised to Transform Care for Pancreatic Cancer
◼ Archived
Business
🔮 holds ✗
SNAP restrictions cut soda purchases but raise stigma concerns, study finds
◼ Archived
Health
🔮 holds ✗